Table of Contents 1 Devic's Disease Drug Market Overview 1.1 Product Overview and Scope of Devic's Disease Drug 1.2 Devic's Disease Drug Segment by Type 1.2.1 Global Devic's Disease Drug Sales Growth Rate Comparison by Type (2021-2026) 1.2.2 Glucocorticoids 1.2.3 Immunoglobulin 1.2.4 Other 1.3 Devic's Disease Drug Segment by Application 1.3.1 Devic's Disease Drug Sales Comparison by Application: 2020 VS 2026 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Others 1.4 Global Devic's Disease Drug Market Size Estimates and Forecasts 1.4.1 Global Devic's Disease Drug Revenue 2015-2026 1.4.2 Global Devic's Disease Drug Sales 2015-2026 1.4.3 Devic's Disease Drug Market Size by Region: 2020 Versus 2026 2 Global Devic's Disease Drug Market Competition by Manufacturers 2.1 Global Devic's Disease Drug Sales Market Share by Manufacturers (2015-2020) 2.2 Global Devic's Disease Drug Revenue Share by Manufacturers (2015-2020) 2.3 Global Devic's Disease Drug Average Price by Manufacturers (2015-2020) 2.4 Manufacturers Devic's Disease Drug Manufacturing Sites, Area Served, Product Type 2.5 Devic's Disease Drug Market Competitive Situation and Trends 2.5.1 Devic's Disease Drug Market Concentration Rate 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 2.7 Primary Interviews with Key Devic's Disease Drug Players (Opinion Leaders) 3 Devic's Disease Drug Retrospective Market Scenario by Region 3.1 Global Devic's Disease Drug Retrospective Market Scenario in Sales by Region: 2015-2020 3.2 Global Devic's Disease Drug Retrospective Market Scenario in Revenue by Region: 2015-2020 3.3 North America Devic's Disease Drug Market Facts & Figures by Country 3.3.1 North America Devic's Disease Drug Sales by Country 3.3.2 North America Devic's Disease Drug Sales by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Devic's Disease Drug Market Facts & Figures by Country 3.4.1 Europe Devic's Disease Drug Sales by Country 3.4.2 Europe Devic's Disease Drug Sales by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Devic's Disease Drug Market Facts & Figures by Region 3.5.1 Asia Pacific Devic's Disease Drug Sales by Region 3.5.2 Asia Pacific Devic's Disease Drug Sales by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Devic's Disease Drug Market Facts & Figures by Country 3.6.1 Latin America Devic's Disease Drug Sales by Country 3.6.2 Latin America Devic's Disease Drug Sales by Country 3.6.3 Mexico 3.6.3 Brazil 3.6.3 Argentina 3.7 Middle East and Africa Devic's Disease Drug Market Facts & Figures by Country 3.7.1 Middle East and Africa Devic's Disease Drug Sales by Country 3.7.2 Middle East and Africa Devic's Disease Drug Sales by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Devic's Disease Drug Historic Market Analysis by Type 4.1 Global Devic's Disease Drug Sales Market Share by Type (2015-2020) 4.2 Global Devic's Disease Drug Revenue Market Share by Type (2015-2020) 4.3 Global Devic's Disease Drug Price Market Share by Type (2015-2020) 4.4 Global Devic's Disease Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Devic's Disease Drug Historic Market Analysis by Application 5.1 Global Devic's Disease Drug Sales Market Share by Application (2015-2020) 5.2 Global Devic's Disease Drug Revenue Market Share by Application (2015-2020) 5.3 Global Devic's Disease Drug Price by Application (2015-2020) 6 Company Profiles and Key Figures in Devic's Disease Drug Business 6.1 Pfizer 6.1.1 Corporation Information 6.1.2 Pfizer Description, Business Overview and Total Revenue 6.1.3 Pfizer Devic's Disease Drug Sales, Revenue and Gross Margin (2015-2020) 6.1.4 Pfizer Products Offered 6.1.5 Pfizer Recent Development 6.2 Fresenius 6.2.1 Fresenius Devic's Disease Drug Production Sites and Area Served 6.2.2 Fresenius Description, Business Overview and Total Revenue 6.2.3 Fresenius Devic's Disease Drug Sales, Revenue and Gross Margin (2015-2020) 6.2.4 Fresenius Products Offered 6.2.5 Fresenius Recent Development 6.3 TEVA 6.3.1 TEVA Devic's Disease Drug Production Sites and Area Served 6.3.2 TEVA Description, Business Overview and Total Revenue 6.3.3 TEVA Devic's Disease Drug Sales, Revenue and Gross Margin (2015-2020) 6.3.4 TEVA Products Offered 6.3.5 TEVA Recent Development 6.4 Sandoz 6.4.1 Sandoz Devic's Disease Drug Production Sites and Area Served 6.4.2 Sandoz Description, Business Overview and Total Revenue 6.4.3 Sandoz Devic's Disease Drug Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Sandoz Products Offered 6.4.5 Sandoz Recent Development 6.5 Intas 6.5.1 Intas Devic's Disease Drug Production Sites and Area Served 6.5.2 Intas Description, Business Overview and Total Revenue 6.5.3 Intas Devic's Disease Drug Sales, Revenue and Gross Margin (2015-2020) 6.5.4 Intas Products Offered 6.5.5 Intas Recent Development 6.6 Gyjtrs 6.6.1 Gyjtrs Devic's Disease Drug Production Sites and Area Served 6.6.2 Gyjtrs Description, Business Overview and Total Revenue 6.6.3 Gyjtrs Devic's Disease Drug Sales, Revenue and Gross Margin (2015-2020) 6.6.4 Gyjtrs Products Offered 6.6.5 Gyjtrs Recent Development 6.7 Nang Kuang 6.6.1 Nang Kuang Devic's Disease Drug Production Sites and Area Served 6.6.2 Nang Kuang Description, Business Overview and Total Revenue 6.6.3 Nang Kuang Devic's Disease Drug Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Nang Kuang Products Offered 6.7.5 Nang Kuang Recent Development 6.8 Tianjin Kingyork 6.8.1 Tianjin Kingyork Devic's Disease Drug Production Sites and Area Served 6.8.2 Tianjin Kingyork Description, Business Overview and Total Revenue 6.8.3 Tianjin Kingyork Devic's Disease Drug Sales, Revenue and Gross Margin (2015-2020) 6.8.4 Tianjin Kingyork Products Offered 6.8.5 Tianjin Kingyork Recent Development 6.9 Baxter 6.9.1 Baxter Devic's Disease Drug Production Sites and Area Served 6.9.2 Baxter Description, Business Overview and Total Revenue 6.9.3 Baxter Devic's Disease Drug Sales, Revenue and Gross Margin (2015-2020) 6.9.4 Baxter Products Offered 6.9.5 Baxter Recent Development 6.10 CSL 6.10.1 CSL Devic's Disease Drug Production Sites and Area Served 6.10.2 CSL Description, Business Overview and Total Revenue 6.10.3 CSL Devic's Disease Drug Sales, Revenue and Gross Margin (2015-2020) 6.10.4 CSL Products Offered 6.10.5 CSL Recent Development 6.11 Grifols 6.11.1 Grifols Devic's Disease Drug Production Sites and Area Served 6.11.2 Grifols Devic's Disease Drug Description, Business Overview and Total Revenue 6.11.3 Grifols Devic's Disease Drug Sales, Revenue and Gross Margin (2015-2020) 6.11.4 Grifols Products Offered 6.11.5 Grifols Recent Development 6.12 Octapharma 6.12.1 Octapharma Devic's Disease Drug Production Sites and Area Served 6.12.2 Octapharma Devic's Disease Drug Description, Business Overview and Total Revenue 6.12.3 Octapharma Devic's Disease Drug Sales, Revenue and Gross Margin (2015-2020) 6.12.4 Octapharma Products Offered 6.12.5 Octapharma Recent Development 6.13 CBOP 6.13.1 CBOP Devic's Disease Drug Production Sites and Area Served 6.13.2 CBOP Devic's Disease Drug Description, Business Overview and Total Revenue 6.13.3 CBOP Devic's Disease Drug Sales, Revenue and Gross Margin (2015-2020) 6.13.4 CBOP Products Offered 6.13.5 CBOP Recent Development 7 Devic's Disease Drug Manufacturing Cost Analysis 7.1 Devic's Disease Drug Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Devic's Disease Drug 7.4 Devic's Disease Drug Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Devic's Disease Drug Distributors List 8.3 Devic's Disease Drug Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porter's Five Forces Analysis 10 Global Market Forecast 10.1 Global Devic's Disease Drug Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Devic's Disease Drug by Type (2021-2026) 10.1.2 Global Forecasted Revenue of Devic's Disease Drug by Type (2021-2026) 10.2 Devic's Disease Drug Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Devic's Disease Drug by Application (2021-2026) 10.2.2 Global Forecasted Revenue of Devic's Disease Drug by Application (2021-2026) 10.3 Devic's Disease Drug Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Devic's Disease Drug by Region (2021-2026) 10.3.2 Global Forecasted Revenue of Devic's Disease Drug by Region (2021-2026) 10.4 North America Devic's Disease Drug Estimates and Projections (2021-2026) 10.5 Europe Devic's Disease Drug Estimates and Projections (2021-2026) 10.6 Asia Pacific Devic's Disease Drug Estimates and Projections (2021-2026) 10.7 Latin America Devic's Disease Drug Estimates and Projections (2021-2026) 10.8 Middle East and Africa Devic's Disease Drug Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Devic's Disease Drug Sales (K MT) Growth Rate Comparison by Type (2015-2026) Table 2. Global Devic's Disease Drug Sales (K MT) Comparison by Application: 2020 VS 2026 Table 3. Global Devic's Disease Drug Market Size by Type (K MT) (US$ Million) (2020 VS 2026) Table 4. Global Key Devic's Disease Drug Manufacturers Covered in This Study Table 5. Global Devic's Disease Drug Sales (K MT) by Manufacturers (2015-2020) Table 6. Global Devic's Disease Drug Sales Share by Manufacturers (2015-2020) Table 7. Global Devic's Disease Drug Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Devic's Disease Drug Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Devic's Disease Drug Average Price (USD/MT) of Key Manufacturers (2015-2020) Table 10. Manufacturers Devic's Disease Drug Sales Sites and Area Served Table 11. Manufacturers Devic's Disease Drug Product Types Table 12. Global Devic's Disease Drug Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Devic's Disease Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Devic's Disease Drug as of 2019) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Devic's Disease Drug Players Table 16. Global Devic's Disease Drug Sales (K MT) by Region (2015-2020) Table 17. Global Devic's Disease Drug Sales Market Share by Region (2015-2020) Table 18. Global Devic's Disease Drug Revenue (Million US$) by Region (2015-2020) Table 19. Global Devic's Disease Drug Revenue Market Share by Region (2015-2020) Table 20. North America Devic's Disease Drug Sales by Country (2015-2020) (K MT) Table 21. North America Devic's Disease Drug Sales Market Share by Country (2015-2020) Table 22. North America Devic's Disease Drug Revenue by Country (2015-2020) (US$ Million) Table 23. North America Devic's Disease Drug Revenue Market Share by Country (2015-2020) Table 24. Europe Devic's Disease Drug Sales by Country (2015-2020) (K MT) Table 25. Europe Devic's Disease Drug Sales Market Share by Country (2015-2020) Table 26. Europe Devic's Disease Drug Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Devic's Disease Drug Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Devic's Disease Drug Sales by Region (2015-2020) (K MT) Table 29. Asia Pacific Devic's Disease Drug Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Devic's Disease Drug Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Devic's Disease Drug Revenue Market Share by Region (2015-2020) Table 32. Latin America Devic's Disease Drug Sales by Country (2015-2020) (K MT) Table 33. Latin America Devic's Disease Drug Sales Market Share by Country (2015-2020) Table 34. Latin America Devic's Disease Drug Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Devic's Disease Drug Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Devic's Disease Drug Sales by Country (2015-2020) (K MT) Table 37. Middle East and Africa Devic's Disease Drug Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Devic's Disease Drug Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Devic's Disease Drug Revenue Market Share by Country (2015-2020) Table 40. Global Devic's Disease Drug Sales (K MT) by Type (2015-2020) Table 41. Global Devic's Disease Drug Sales Share by Type (2015-2020) Table 42. Global Devic's Disease Drug Revenue (Million US$) by Type (2015-2020) Table 43. Global Devic's Disease Drug Revenue Share by Type (2015-2020) Table 44. Global Devic's Disease Drug Price (USD/MT) by Type (2015-2020) Table 45. Global Devic's Disease Drug Sales (K MT) by Application (2015-2020) Table 46. Global Devic's Disease Drug Sales Market Share by Application (2015-2020) Table 47. Global Devic's Disease Drug Sales Growth Rate by Application (2015-2020) Table 48. Pfizer Devic's Disease Drug Corporation Information Table 49. Pfizer Description and Business Overview Table 50. Pfizer Devic's Disease Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 51. Pfizer Main Product Table 52. Pfizer Recent Development Table 53. Fresenius Devic's Disease Drug Corporation Information Table 54. Fresenius Corporation Information Table 55. Fresenius Devic's Disease Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 56. Fresenius Main Product Table 57. Fresenius Recent Development Table 58. TEVA Devic's Disease Drug Corporation Information Table 59. TEVA Corporation Information Table 60. TEVA Devic's Disease Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 61. TEVA Main Product Table 62. TEVA Recent Development Table 63. Sandoz Devic's Disease Drug Corporation Information Table 64. Sandoz Corporation Information Table 65. Sandoz Devic's Disease Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 66. Sandoz Main Product Table 67. Sandoz Recent Development Table 68. Intas Devic's Disease Drug Corporation Information Table 69. Intas Corporation Information Table 70. Intas Devic's Disease Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 71. Intas Main Product Table 72. Intas Recent Development Table 73. Gyjtrs Devic's Disease Drug Corporation Information Table 74. Gyjtrs Corporation Information Table 75. Gyjtrs Devic's Disease Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 76. Gyjtrs Main Product Table 77. Gyjtrs Recent Development Table 78. Nang Kuang Devic's Disease Drug Corporation Information Table 79. Nang Kuang Corporation Information Table 80. Nang Kuang Devic's Disease Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 81. Nang Kuang Main Product Table 82. Nang Kuang Recent Development Table 83. Tianjin Kingyork Devic's Disease Drug Corporation Information Table 84. Tianjin Kingyork Corporation Information Table 85. Tianjin Kingyork Devic's Disease Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 86. Tianjin Kingyork Main Product Table 87. Tianjin Kingyork Recent Development Table 88. Baxter Devic's Disease Drug Corporation Information Table 89. Baxter Corporation Information Table 90. Baxter Devic's Disease Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 91. Baxter Main Product Table 92. Baxter Recent Development Table 93. CSL Devic's Disease Drug Corporation Information Table 94. CSL Corporation Information Table 95. CSL Devic's Disease Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 96. CSL Main Product Table 97. CSL Recent Development Table 98. Grifols Devic's Disease Drug Corporation Information Table 99. Grifols Corporation Information Table 100. Grifols Devic's Disease Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 101. Grifols Main Product Table 102. Grifols Recent Development Table 103. Octapharma Devic's Disease Drug Corporation Information Table 104. Octapharma Corporation Information Table 105. Octapharma Devic's Disease Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 106. Octapharma Main Product Table 107. Octapharma Recent Development Table 108. CBOP Devic's Disease Drug Corporation Information Table 109. CBOP Corporation Information Table 110. CBOP Devic's Disease Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 111. CBOP Main Product Table 112. CBOP Recent Development Table 113. Sales Base and Market Concentration Rate of Raw Material Table 114. Key Suppliers of Raw Materials Table 115. Devic's Disease Drug Distributors List Table 116. Devic's Disease Drug Customers List Table 117. Market Key Trends Table 118. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 119. Key Challenges Table 120. Global Devic's Disease Drug Sales (K MT) Forecast by Type (2021-2026) Table 121. Global Devic's Disease Drug Sales Market Share Forecast by Type (2021-2026) Table 122. Global Devic's Disease Drug Revenue (Million US$) Forecast by Type (2021-2026) Table 123. Global Devic's Disease Drug Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 124. Global Devic's Disease Drug Sales (K MT) Forecast by Application (2021-2026) Table 125. Global Devic's Disease Drug Revenue (Million US$) Forecast by Application (2021-2026) Table 126. Global Devic's Disease Drug Sales (K MT) Forecast by Region (2021-2026) Table 127. Global Devic's Disease Drug Sales Market Share Forecast by Region (2021-2026) Table 128. Global Devic's Disease Drug Revenue Forecast by Region (2021-2026) (US$ Million) Table 129. Global Devic's Disease Drug Revenue Market Share Forecast by Region (2021-2026) Table 130. Research Programs/Design for This Report Table 131. Key Data Information from Secondary Sources Table 132. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Devic's Disease Drug Figure 2. Global Devic's Disease Drug Sales Market Share by Type: 2020 VS 2026 Figure 3. Glucocorticoids Product Picture Figure 4. Immunoglobulin Product Picture Figure 5. Other Product Picture Figure 6. Global Devic's Disease Drug Consumption Market Share by Application: 2020 VS 2026 Figure 7. Hospitals Figure 8. Clinics Figure 9. Others Figure 10. Global Devic's Disease Drug Market Size 2015-2026 (US$ Million) Figure 11. Global Devic's Disease Drug Sales Capacity (K MT) (2015-2026) Figure 12. Global Devic's Disease Drug Market Size Market Share by Region: 2020 Versus 2026 Figure 13. Devic's Disease Drug Sales Share by Manufacturers in 2020 Figure 14. Global Devic's Disease Drug Revenue Share by Manufacturers in 2019 Figure 15. The Global 5 and 10 Largest Players: Market Share by Devic's Disease Drug Revenue in 2019 Figure 16. Devic's Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 17. Global Devic's Disease Drug Sales Market Share by Region (2015-2020) Figure 18. Global Devic's Disease Drug Sales Market Share by Region in 2019 Figure 19. Global Devic's Disease Drug Revenue Market Share by Region (2015-2020) Figure 20. Global Devic's Disease Drug Revenue Market Share by Region in 2019 Figure 21. North America Devic's Disease Drug Sales Market Share by Country in 2019 Figure 22. North America Devic's Disease Drug Revenue Market Share by Country in 2019 Figure 23. U.S. Devic's Disease Drug Sales Growth Rate (2015-2020) (K MT) Figure 24. U.S. Devic's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 25. Canada Devic's Disease Drug Sales Growth Rate (2015-2020) (K MT) Figure 26. Canada Devic's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 27. Europe Devic's Disease Drug Sales Market Share by Country in 2019 Figure 28. Europe Devic's Disease Drug Revenue Market Share by Country in 2019 Figure 29. Germany Devic's Disease Drug Sales Growth Rate (2015-2020) (K MT) Figure 30. Germany Devic's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 31. France Devic's Disease Drug Sales Growth Rate (2015-2020) (K MT) Figure 32. France Devic's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 33. U.K. Devic's Disease Drug Sales Growth Rate (2015-2020) (K MT) Figure 34. U.K. Devic's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 35. Italy Devic's Disease Drug Sales Growth Rate (2015-2020) (K MT) Figure 36. Italy Devic's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 37. Russia Devic's Disease Drug Sales Growth Rate (2015-2020) (K MT) Figure 38. Russia Devic's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 39. Asia Pacific Devic's Disease Drug Sales Market Share by Region in 2019 Figure 40. Asia Pacific Devic's Disease Drug Revenue Market Share by Region in 2019 Figure 41. China Devic's Disease Drug Sales Growth Rate (2015-2020) (K MT) Figure 42. China Devic's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 43. Japan Devic's Disease Drug Sales Growth Rate (2015-2020) (K MT) Figure 44. Japan Devic's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 45. South Korea Devic's Disease Drug Sales Growth Rate (2015-2020) (K MT) Figure 46. South Korea Devic's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 47. India Devic's Disease Drug Sales Growth Rate (2015-2020) (K MT) Figure 48. India Devic's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 49. Australia Devic's Disease Drug Sales Growth Rate (2015-2020) (K MT) Figure 50. Australia Devic's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. Taiwan Devic's Disease Drug Sales Growth Rate (2015-2020) (K MT) Figure 52. Taiwan Devic's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. Indonesia Devic's Disease Drug Sales Growth Rate (2015-2020) (K MT) Figure 54. Indonesia Devic's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Thailand Devic's Disease Drug Sales Growth Rate (2015-2020) (K MT) Figure 56. Thailand Devic's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Malaysia Devic's Disease Drug Sales Growth Rate (2015-2020) (K MT) Figure 58. Malaysia Devic's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 59. Philippines Devic's Disease Drug Sales Growth Rate (2015-2020) (K MT) Figure 60. Philippines Devic's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 61. Vietnam Devic's Disease Drug Sales Growth Rate (2015-2020) (K MT) Figure 62. Vietnam Devic's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 63. Latin America Devic's Disease Drug Sales Market Share by Country in 2019 Figure 64. Latin America Devic's Disease Drug Revenue Market Share by Country in 2019 Figure 65. Mexico Devic's Disease Drug Sales Growth Rate (2015-2020) (K MT) Figure 66. Mexico Devic's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 67. Brazil Devic's Disease Drug Sales Growth Rate (2015-2020) (K MT) Figure 68. Brazil Devic's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. Argentina Devic's Disease Drug Sales Growth Rate (2015-2020) (K MT) Figure 70. Argentina Devic's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 71. Middle East and Africa Devic's Disease Drug Sales Market Share by Country in 2019 Figure 72. Middle East and Africa Devic's Disease Drug Revenue Market Share by Country in 2019 Figure 73. Turkey Devic's Disease Drug Sales Growth Rate (2015-2020) (K MT) Figure 74. Turkey Devic's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. Saudi Arabia Devic's Disease Drug Sales Growth Rate (2015-2020) (K MT) Figure 76. Saudi Arabia Devic's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. U.A.E Devic's Disease Drug Sales Growth Rate (2015-2020) (K MT) Figure 78. U.A.E Devic's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 79. Sales Market Share of Devic's Disease Drug by Type (2015-2020) Figure 80. Sales Market Share of Devic's Disease Drug by Type in 2019 Figure 81. Revenue Share of Devic's Disease Drug by Type (2015-2020) Figure 82. Revenue Market Share of Devic's Disease Drug by Type in 2019 Figure 83. Global Devic's Disease Drug Sales Growth by Type (2015-2020) (K MT) Figure 84. Global Devic's Disease Drug Sales Market Share by Application (2015-2020) Figure 85. Global Devic's Disease Drug Sales Market Share by Application in 2019 Figure 86. Global Revenue Share of Devic's Disease Drug by Application (2015-2020) Figure 87. Global Revenue Share of Devic's Disease Drug by Application in 2020 Figure 88. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 89. Fresenius Total Revenue (US$ Million): 2019 Compared with 2018 Figure 90. TEVA Total Revenue (US$ Million): 2019 Compared with 2018 Figure 91. Sandoz Total Revenue (US$ Million): 2019 Compared with 2018 Figure 92. Intas Total Revenue (US$ Million): 2019 Compared with 2018 Figure 93. Gyjtrs Total Revenue (US$ Million): 2019 Compared with 2018 Figure 94. Nang Kuang Total Revenue (US$ Million): 2019 Compared with 2018 Figure 95. Tianjin Kingyork Total Revenue (US$ Million): 2019 Compared with 2018 Figure 96. Baxter Total Revenue (US$ Million): 2019 Compared with 2018 Figure 97. CSL Total Revenue (US$ Million): 2019 Compared with 2018 Figure 98. Grifols Total Revenue (US$ Million): 2019 Compared with 2018 Figure 99. Octapharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 100. CBOP Total Revenue (US$ Million): 2019 Compared with 2018 Figure 101. Price Trend of Key Raw Materials Figure 102. Manufacturing Cost Structure of Devic's Disease Drug Figure 103. Manufacturing Process Analysis of Devic's Disease Drug Figure 104. Devic's Disease Drug Industrial Chain Analysis Figure 105. Channels of Distribution Figure 106. Distributors Profiles Figure 107. Porter's Five Forces Analysis Figure 108. North America Devic's Disease Drug Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 109. North America Devic's Disease Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 110. Europe Devic's Disease Drug Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 111. Europe Devic's Disease Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 112. Latin America Devic's Disease Drug Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 113. Latin America Devic's Disease Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 114. Middle East and Africa Devic's Disease Drug Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 115. Middle East and Africa Devic's Disease Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 116. Asia Pacific Devic's Disease Drug Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 117. Asia Pacific Devic's Disease Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 118. Bottom-up and Top-down Approaches for This Report Figure 119. Data Triangulation Figure 120. Key Executives Interviewed

Pfizer Fresenius TEVA Sandoz Intas Gyjtrs Nang Kuang Tianjin Kingyork Baxter CSL Grifols Octapharma CBOP